Stock Alert: NuVasive Down 7%

Shares of NuVasive, Inc. (NUVA), a developer of minimally disruptive surgical products for spine surgery, are declining more than 7 percent or $3.51 in Friday's morning trade at $45.76 despite its third-quarter results beating analysts' estimates.

from RTT - Earnings https://ift.tt/34GQeLT
via IFTTT

Stock Alert: Acadia Healthcare Up 20% On Quarterly Results, Outlook

Shares of Acadia Healthcare Company, Inc. (ACHC) are jumping over 20% on Friday morning after the company reported third-quarter results that trumped Wall Street estimates and issued a fourth-quarter outlook, which is above current expectations.

from RTT - Earnings https://ift.tt/3mB48VR
via IFTTT

Stock Alert: Seagen Tumbles 9%

Shares of Seagen Inc. (SGEN) are losing more than 9 percent or $17.43 in Friday's morning trade at $174.91 despite the biotechnology company's third-quarter results beating analysts' estimates.

from RTT - Earnings https://ift.tt/35UgzFM
via IFTTT

Stock Alert: Trupanion Jumps 13%

Shares of Trupanion Inc. (TRUP) are gaining over 13% on Friday morning after its third-quarter revenues trumped Wall Street estimates. Trupanion also announced a distribution agreement with Aflac Inc. (AFL).

from RTT - Earnings https://ift.tt/2HHjQAa
via IFTTT

Shaw Communications Q4 Profit Rises, Results Beat Estimates - Quick Facts

Shaw Communications Inc. (SJR) on Friday reported an increase in net income for the fourth quarter to C$175 million or C$0.34 per share from C$166 million or C$0.32 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2TJQPpz
via IFTTT

Exxon Mobil Q3 Results Above Estimates, To Cut 2021 Capital Program; Chevron Reports Adj. Profit

Exxon Mobil Corp. (XOM), one of the world's largest publicly traded energy providers and chemical manufacturers, reported third quarter results which came in better than analysts' projections. Exxon Mobil said it is on track to exceed reduction targets for 2020 capital and cash expenses; with further reductions anticipated in 2021. Separately, Chevron, the human energy company, reported third quarter results which were down from a year ago, primarily due to lower commodity prices and margins resulting from the impact of COVID-19.

from RTT - Earnings https://ift.tt/3ecqEla
via IFTTT

Negative Reaction To Earnings News May Weigh On Wall Street

The major U.S. index futures are currently pointing to a lower open on Friday, with stocks likely to move back to the downside following the rebound seen in the previous session.

from RTT - Market Analysis https://ift.tt/380VcFr
via IFTTT

American Axle & Manufacturing Turns To Profit In Q3, Beats Estimates

Automotive supplier American Axle & Manufacturing Holdings Inc. or AAM (AXL) on Friday reported that its net income for the third quarter was $117.2 million or $0.99 per share, compared to net loss of $124.2 million or $1.10 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/3oEG8mA
via IFTTT

Ligand Pharma Reiterates FY20, FY21 Outlook - Quick Facts

While reporting financial results for the third quarter on Friday, biopharmaceutical company Ligand Pharmaceuticals Inc. (LGND) reiterated its adjusted earnings and revenue guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2JmrL6j
via IFTTT

First BanCorp Q3 Profit Declines, Misses Estimates - Quick Facts

First BanCorp. (FBP), the bank holding company for FirstBank Puerto Rico, on Friday reported net income for the third quarter of $28.6 million or $0.13 per share, down from $45.7 million or $0.21 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2HKD07U
via IFTTT

AbbVie Raises FY20 Adj. EPS Outlook; Boosts Dividend 10.2% - Quick Facts

While reporting financial results for the third quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2Gcvt13
via IFTTT

FLIR Systems Reinitiates And Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Friday, industrial technology company FLIR Systems, Inc. (FLIR) reinitiated its adjusted earnings and revenue guidance for the full-year 2020, based on our year-to-date performance and updated expectations for the remainder or the year.

from RTT - Earnings https://ift.tt/35QE5TZ
via IFTTT

W.P. Carey Reinstates FY20 AFFO Outlook - Quick Facts

While reporting its financial results for the third quarter on Friday, W.P. Carey Inc. (WPC) said it has reinstated its guidance for fiscal 2020, and expects to report total adjusted funds from operations or AFFO of between $4.65 and $4.75 per share, including Real Estate AFFO of between $4.51 and $4.61 per share.

from RTT - Earnings https://ift.tt/2HRkRW9
via IFTTT

Public Service Enterprise Boosts FY20 Operating Earnings Outlook - Quick Facts

While reporting financial results for the first quarter on Thursday, Public Service Enterprise Group, Inc. (PEG) raised its full-year 2020 guidance for operating earnings to reflect strong cost control at PSEG Power and overall results through the first three quarters of the year.

from RTT - Earnings https://ift.tt/35N2SrZ
via IFTTT

Altria Raises FY20 Adj. EPS Outlook - Quick Facts

While reporting its financial results for the third quarter on Friday, Altria Group, Inc. (MO) raised its adjusted earnings guidance for the fu-year 2020, based on year-to-date performance and insight into an additional quarter of ABI earnings contributions.

from RTT - Earnings https://ift.tt/3edWrSK
via IFTTT

Colgate-Palmolive Reinitiates FY20 Outlook; Q3 Results Top View - Quick Facts

While reporting financial results for the third quarter on Friday, Colgate-Palmolive Co. (CL) reinitiated its earnings and sales growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3jIrwiu
via IFTTT

L3Harris Technologies Boosts FY20 Earnings Outlook - Quick Facts

While reporting financial results for the third quarter on Friday, aerospace and defense technology firm L3Harris Technologies, Inc. (LHX) raised its earnings and adjusted earnings guidance for the full-year 2020, while maintaining annual revenue outlook at the mid-point of the previous guidance range.

from RTT - Earnings https://ift.tt/37VmVqI
via IFTTT

Honeywell Reinstates FY20 Outlook Above Estimates - Quick Facts

While reporting financial results for the third quarter on Friday, technology company Honeywell international Inc. (HON) reinstated its earnings, adjusted earnings and sales guidance for the full-year 2020. It also provided financial outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/3oIUFgW
via IFTTT

Pre-market Movers In Healthcare Sector: MGEN, EQ, SNSS, IPHA, BLCM, AXGT.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/34Fm8bn
via IFTTT

Fortis Q3 Profit Declines; Adj. EPS Misses View - Quick Facts

Electric and gas utility Fortis Inc. (FTS, FTS.TO) reported third quarter net earnings attributable to common equity shareholders of C$292 million, up from C$278 million in the prior-year quarter.

from RTT - Earnings https://ift.tt/3kHmxj7
via IFTTT

Lear Reinitiates FY20 Sales Outlook In Line With Estimates - Quick Facts

While reporting financial results for the third quarter on Friday, automotive technology firm Lear Corp. (LEA) reinstated financial outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/35G5S9m
via IFTTT

This Day That Year: RAPT Therapeutics (RAPT)

Shares of RAPT Therapeutics Inc. (RAPT) are down nearly 42 percent from their 52-week high of $51.21, recorded in January of this year, and trade around $29.

from RTT - Biotech https://ift.tt/31XTZuF
via IFTTT

AXGT's Parkinson's Gene Therapy Trial To Be Delayed, BLCM To Trim Workforce, MRNA On Watch

Today's Daily Dose brings you news about Axovant's update on its EXPLORE-PD study of AXO-Lenti-PD gene therapy in Parkinson's disease, disappointing data from Bellicum's pancreatic cancer trial, vTv Therapeutics' progress in Elevage study, and the near-term catalysts related to Moderna's COVID-19 vaccine candidate.

from RTT - Biotech https://ift.tt/3jCbfeJ
via IFTTT

Group 1 Automotive Q3 Profit More Than Triples; Results Beat View

Group 1 Automotive Inc. (GPI), an automotive retailer, on Thursday reported third-quarter net income of $121.9 million or $6.83 per share, up sharply from $36.7 million or $2.04 per share in the year-ago period.

from RTT - Earnings https://ift.tt/34DJjDh
via IFTTT

Brink's Reinstates FY20 Outlook Well Above Estimates; Shares Up 18% - Quick Facts

While reporting financial results for the third quarter on Thursday, The Brink's Co. (BCO) reinstated its earnings and revenue guidance for the full-year 2020, well above analysts' estimates.

from RTT - Earnings https://ift.tt/35H5848
via IFTTT

Allegheny Technologies Says Expects Q4 Results To Be Negatively Impacted By COVID-19

While reporting its financial results for the third quarter on Thursday, Allegheny Technologies Inc. (ATI) said it expects its fourth-quarter results to be negatively affected by the ongoing pandemic, including the impact on commercial aerospace, the company's largest end-market.

from RTT - Earnings https://ift.tt/2TB7dsw
via IFTTT

Charles River Labs Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings and revenue growth guidance for the full-year 2020, due to the better-than-expected third quarter performance.

from RTT - Earnings https://ift.tt/2Txi4DZ
via IFTTT

Comcast Q3 Profit Declines 37%, But Results Top Estimates

Comcast Corp. on Thursday reported a 37 percent decline in profit for the third quarter from last year, hurt primarily by revenue decline at NBCUniversal. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend. In the pre-market trade, CMCSA is trading at $42.83, up $0.85 or 2.02 percent.

from RTT - Earnings https://ift.tt/3e9JusM
via IFTTT

LVMH agrees $15.8bn takeover of Tiffany

Discount of $425m ends acrimonious battle over luxury sector’s biggest-ever deal

France’s LVMH will pay slightly less to buy the US jeweller Tiffany & Co after the two firms agreed to end a bitter dispute triggered by the Covid-19 pandemic and salvage the luxury sector’s biggest-ever deal.

The new takeover price was set at $131.5 (£101.6) a share, down from $135 in the original deal, the companies said on Thursday, bringing the total price tag to about $15.8bn.

LVMH, or Moët Hennessy Louis Vuitton, is the world’s biggest luxury goods group and is owned and run by Bernard Arnault, Europe’s richest man. Here are its main brands.

Related: Luxury player: why Bernard Arnault is making a blockbuster bid for Tiffany’s

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/31Qtlnu

Brunswick Guides FY20, FY21 Adj. EPS Above Estimates - Quick Facts

While reporting financial results for the third quarter on Thursday, Brunswick Corp. (BC) provided adjusted earnings guidance range for the full-year 2020. It also provided revenue growth guidance for the fourth quarter and initiated outlook for the full-year 2021.

from RTT - Earnings https://ift.tt/3e95XGD
via IFTTT

Myers Industries Boosts FY20 Revenue Growth Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, polymer products maker Myers Industries, Inc. (MYE) said it now expects total revenue for the full-year 2020 to decline in the low-to-mid single digits, which is a slight improvement from its previous guidance of a decline in the mid-to-high single digit range.

from RTT - Earnings https://ift.tt/35Zk1yX
via IFTTT

M.D.C Holdings Promotes COO David Mandarich To CEO; Boosts Dividend 33% - Quick Facts

While reporting financial results for the third quarter on Thursday, M.D.C Holdings Inc. (MDC) announced a number of promotions and changes with the Company's senior management team. The company also raised its quarterly cash dividend 33 percent year-over-year.

from RTT - Earnings https://ift.tt/37PUkDp
via IFTTT

Regeneron Says Its Covid-19 Outpatient Therapy Could Reduce Virus Levels

Regeneron announced positive results from its late stage COVID-19 outpatient trial, indicating that its antibody cocktail therapy significantly reduced virus levels and need for further medical attention. The trial results showed that investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.

from RTT - Biotech https://ift.tt/37PSLp1
via IFTTT

Pre-market Movers In Healthcare Sector: VSTM, APM, KALA, BNTX, CGIX...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3e7Vb3j
via IFTTT

DuPont Reinstates FY20 Adj. EPS Outlook Above View - Quick Facts

While reporting financial results for the third quarter on Thursday, DuPont (DD) reinstated its adjusted earnings and net sales guidance for the full year 2020.

from RTT - Earnings https://ift.tt/37RcdSn
via IFTTT

United Microelectronics Q3 Profit Soars - Quick Facts

Semiconductor foundry United Microelectronics Corp. (UMC) reported Thursday third-quarter net income attributable to stockholders of the parent that soared to NT$9.11 billion or US$313 million, from NT$2.93 billion or US$101 million last year.

from RTT - Earnings https://ift.tt/2HJqAxi
via IFTTT

Advantest H1 Profit Down 8.5%; Raises FY Outlook - Quick Facts

Advantest Corp. (ATE), a Japan-based manufacturer of automatic test equipment for the semiconductor industry, reported Thursday that its first-half net income attributable to owners of the parent declined 8.5 percent to 24.49 billion yen from 26.77 billion yen in the year-ago period. Earnings per share were 122.97 yen, down from 134.77 yen a year ago.

from RTT - Earnings https://ift.tt/2HEhxxf
via IFTTT

NTT Docomo H1 Profit Up 5.1%; Affirms FY Outlook - Quick Facts

NTT Docomo, Inc. (DCM) reported Thursday that its first-half profit attributable to shareholders rose 5.1 percent to 391.30 billion yen from last year's 372.35 billion yen. Basic earnings per share were 121.20 yen, up from 112.33 yen in the year-ago period.

from RTT - Earnings https://ift.tt/31VMwfE
via IFTTT

EVRAZ Q3 Crude Steel Production Down 4.4% QoQ - Quick Facts

EVRAZ plc (EVR.L) reported Thursday that its third-quarter consolidated crude steel output decreased by 4.4 percent from the preceding second quarter, mainly due to the planned shutdown of blast furnace number 5 and the launch of blast furnace number 6 after the completion of a major overhaul at EVRAZ NTMK.

from RTT - Earnings https://ift.tt/34Cta0y
via IFTTT

KAZ Minerals Q3 Copper Production Declines - Quick Facts

Copper producer KAZ Minerals Plc (KAZ.L), formerly Kazakhmys PLC, reported Thursday that its copper production in the third quarter decreased to 76.2 kt from 78.9 kt in the preceding second quarter. Copper production also declined from 82.9 kt in the year-ago period.

from RTT - Earnings https://ift.tt/31RdyVt
via IFTTT

Smith+Nephew Q3 Revenue Down 3.7% - Quick Facts

Medical technology business Smith+Nephew Plc (SN.L, SNN) reported Thursday that its third-quarter revenue declined 3.7 percent on a reported basis and 4.2 percent on an underlying basis, to $1.20 billion.

from RTT - Earnings https://ift.tt/3ozCvyh
via IFTTT

BT Group H1 Pre-tax Profit Down 20%; Lifts Low End Of FY Adj. EBITDA Outlook Range

Telecom company BT Group plc (BT_A.L, BT) reported Thursday that its first-half profit before tax was 1.06 billion pounds, down 20 percent from 1.33 billion pounds in the year-ago period.

from RTT - Earnings https://ift.tt/34DodVy
via IFTTT

Kuka Q3 EBIT Down 78.7%; Sees Negative EBIT Margin For FY - Quick Facts

Kuka AG (KUKAY.PK, KUKAF.PK) reported Thursday that its third-quarter earnings before interest and taxes or EBIT plunged 78.7 percent to 7.6 million euros from 35.6 million euros in the year-ago period, while the EBIT margin dropped to 1.1 percent from 4.3 percent lat year.

from RTT - Earnings https://ift.tt/37RpyK8
via IFTTT

Orange Q3 Revenue Rises; Affirms FY20 Outlook - Quick Facts

French telecommunications operator Orange Group (ORAN) said Thursday that it returned to revenue growth in the third quarter despite the impact of the COVID-19 crisis.

from RTT - Earnings https://ift.tt/3e8ksdM
via IFTTT

Fresenius Q3 Profit Down 4%; Affirms FY20 Outlook - Quick Facts

Fresenius SE (FSNUF.PK, FSNPF.PK) reported Thursday that its net income attributable to shareholders for the third quarter declined 4 percent to 427 million euros from 444 million euros in the year-ago period. Earnings per ordinary share decreased to 0.77 euros from 0.80 euros in the prior-year quarter.

from RTT - Earnings https://ift.tt/2TwaIR2
via IFTTT

Nokia Q3 Profit Surges, But Revenue Declines; Adjusts FY Outlook - Quick Facts

Nokia Corp. (NOK) on Thursday reported that its profit for the third quarter surged to 203 million euros or 0.04 euros per share from 87 million euros or 0.01 euros per share in the previous-year quarter.

from RTT - Earnings https://ift.tt/37Uyi2f
via IFTTT

Stock Alert: Community Health Systems Climbs 28% As Q3 Results Beat Estimates

Shares of Community Health Systems, Inc. (CYH), an operator of general acute care hospitals, are gaining more than 28 percent or $1.24 in Wednesday's morning trade at $5.63.

from RTT - Earnings https://ift.tt/2TzkotX
via IFTTT

Stock Alert: Mastercard Tumbles 7% As Q3 Results Miss Estimates

Shares of Mastercard Inc. (MA) are losing almost 7 percent or $21.51 in Wednesday's morning trade at $295.60 after the company's third-quarter results missed analysts' expectations.

from RTT - Earnings https://ift.tt/3mBl3rz
via IFTTT

Standard Motor Products Q3 Profit Surges; Reinstates Dividend - Quick Facts

Standard Motor Products, Inc. (SMP), an automotive replacement parts manufacturer and distributor, reported Wednesday that its net income for the third quarter rose to $28.63 million or $1.26 per share from $14.75 million or $0.65 per share in the year-ago period.

from RTT - Earnings https://ift.tt/31PIFR8
via IFTTT

M/I Homes Q3 Profit Surges, Results Beat View - Quick Facts

M/I Homes, Inc. (MHO), a builder of single-family homes, on Wednesday reported a surge in third-quarter net income to $73.54 million or $2.51 per share from $37.84 million or $1.32 per share in the year-ago period.

from RTT - Earnings https://ift.tt/31O4QXQ
via IFTTT

Astellas Pharma: FDA Grants Fast Track Designation For ASP5354 - Quick Facts

Japan-based Astellas Pharma Inc. (ALPMY) said Wednesday that the U.S. Food and Drug Administration or FDA has granted Fast Track designation for the development of ASP5354, based on non-clinical and clinical data.

from RTT - Biotech https://ift.tt/3mn8MXw
via IFTTT

Jump In Coronavirus Cases May Lead To Sell-Off On Wall Street

The major U.S. index futures are pointing to a sharply lower open on Wednesday following the mixed performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/34BZRLL
via IFTTT

Applied Industrial Guides Q2 Sales; Declares Dividend - Quick Facts

While reporting financial results for the first quarter of fiscal 2021 on Wednesday, Applied Industrial Technologies Inc. (AIT) provided sales growth guidance for the second quarter, based on mid-teen organic sales declines month to date in October and assuming sales trend in line with normal seasonal patterns for the remainder of the quarter.

from RTT - Earnings https://ift.tt/3ozECCb
via IFTTT

Deutsche Bank Posts Profit In Q3; On Track To Meet View; Stock Up

Shares of Deutsche Bank AG were gaining around 3 percent in German trading after the banking major reported Wednesday a profit in its third quarter, compared to prior year's loss mainly driven by strong Investment Bank revenues. Looking ahead, the bank said it remains on track to meet all financial and strategic targets related to its transformation plan.

from RTT - Earnings https://ift.tt/35KKRKK
via IFTTT

MarineMax Guides FY21 EPS Well Above Estimates - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2020 on Wednesday, recreational boat and yacht retailer MarineMax Inc. (HZO) provided earnings guidance for the full-year 2021.

from RTT - Earnings https://ift.tt/3jHZKCQ
via IFTTT

Belden Turns To Profit In Q3 - Quick Facts

Belden Inc. (BDC), a supplier of specialty networking solutions, on Wednesday reported attributable net income for the third quarter of $17.00 million or $0.38 per share, compared to net loss of $297.98 million or $6.70 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3e2pnNa
via IFTTT

Silicon Labs Guides Q4 Revenues Above Estimates - Quick Facts

While reporting financial results for the third quarter on Wednesday, Silicon Laboratories Inc. (SLAB) provided earnings and revenue guidance for the fourth quarter.

from RTT - Earnings https://ift.tt/2Tw9CEV
via IFTTT

Brinker International Guides Q1 Adj. EPS In Line With Estimates - Quick Facts

While reporting financial results for the first quarter of fiscal 2021 on Wednesday, casual dining restaurant owner Brinker International, Inc. (EAT) provided guidance for the second quarter of fiscal 2021. However, the company refrained from its usual practice of providing an annual outlook and continued with the quarterly outlook.

from RTT - Earnings https://ift.tt/3kCzJ9b
via IFTTT

Dynatrace Raises FY21 Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) raised its adjusted earnings and revenue guidance for the full-year 2021 and provided outlook for the third quarter.

from RTT - Earnings https://ift.tt/3eaXgvp
via IFTTT

Pre-market Movers In Healthcare Sector: SRRK, SELB, NVIV, NVCN, BNTX.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3oyUrJs
via IFTTT

Anthem Backs FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, Anthem Inc. (ANTM) maintained its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/37PAc4q
via IFTTT

Bunge Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, agribusiness and food company Bunge Ltd. (BG) raised its adjusted earnings guidance for the full year 2020 to a range of $6.25 to $6.75 per share, based on the strong results in the third quarter and improving market trends.

from RTT - Earnings https://ift.tt/2HGxCCZ
via IFTTT

AUPH Initiates VOCOVID Trial, KALA Gets FDA Nod, NVAX Expands COVID-19 Vaccine Study Size In UK

Today's Daily Dose brings you news about Aurinia initiating a trial of its lead candidate Voclosporin in kidney transplant recipients with COVID-19, Exact Sciences' Q3 financial results, FDA approval of Kala Pharma's EYSUVIS 0.25% for dry eye disease, update on Novavax's COVID-19 vaccine trials, and Scholar Rock's spinal muscular atrophy trial results.

from RTT - Biotech https://ift.tt/3kN70hK
via IFTTT

Incredible Fish Recalls Stone Crab Mustard Sauce

Incredible Fish, Inc. has recalled a small quantity of Incredible Stone Crab Mustard Sauce citing undeclared milk, fish, and eggs allergens, the U.S. Food and Drug Administration announced. The Miami-based wholesale seafood distributor sold the recalled product to a limited number of consumers between October 15 and October 22, 2020, primarily through the company's website.

from RTT - Biotech https://ift.tt/2G5uJuJ
via IFTTT

Stock Alert: Varonis Systems Shares Surge 12% In Premarket

Shares of Varonis Systems Inc. (VRNS) are surging over 12% in pre-market today, after the company issued upbeat Q4 guidance, while reporting better-than-expected Q3 results. The stock has been trading in the range of $48.95 - $130.91 for the past one year, and is currently trading at $137.40, up $14.97 or 12.23% in the pre-market session Tuesday.

from RTT - Before the Bell https://ift.tt/3mvqwA7
via IFTTT

Stock Alert: Harley-Davidson Shares Up 9% In Early Trade

Shares of Harley-Davidson Inc. (HOG) are rising over 9% in pre-market today, after the company reported better-than-expected Q3 results. The stock has been trading in the range of $14.31 - $40.86 for the past one year, and is currently trading at $31.73, up $2.74 or 9.45% in the pre-market session Tuesday.

from RTT - Before the Bell https://ift.tt/2HBt0Of
via IFTTT

Franklin Resources Q4 Profit Falls, Revenue Rises - Quick Facts

Franklin Resources, Inc. (BEN) on Tuesday reported preliminary net income for the fourth quarter of $78.9 million or $0.15 per share, down sharply from $306.4 million or $0.61 per share in the year-ago period.

from RTT - Earnings https://ift.tt/37J5vgX
via IFTTT

Lincoln Electric Q2 Results Top Estimates; Boosts Dividend 4.1% - Quick Facts

Lincoln Electric Holdings, Inc. (LECO) reported Tuesday that net income for the third quarter declined to $58.5 million or $0.97 per share from $72.5 million or $1.17 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2HC2nIP
via IFTTT

Bargain Hunting May Lead To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to regain ground following the sharp drop seen in the previous session.

from RTT - Market Analysis https://ift.tt/35F3dwU
via IFTTT

S&P Global Raises FY20 Adj. Earnings Outlook - Quick Facts

While reporting its financial results for the third quarter on Tuesday, S&P Global (SPGI) lowered its outlook for fiscal 2020 reported earnings to a range of $10.00 to $10.15 per share, from the prior range of $10.25 to $10.45 per share. The company noted that the outlook does not reflect potential future impairment charges relating to the new productivity program that are not quantifiable at this time.

from RTT - Earnings https://ift.tt/37FBPBw
via IFTTT

Sherwin-Williams Raises FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, paint and coating manufacturer Sherwin-Williams Co. (SHW) raised its earnings and sales growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/31O9wx0
via IFTTT

MakeMyTrip Q2 Loss Narrows, But Revenue Falls - Quick Facts

MakeMyTrip Ltd. (MMYT), an India-based online travel company, on Tuesday reported second-quarter loss attributable to owners of the company of $21.05 million or $0.20 per share, narrower than loss of $36.93 million or $0.35 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2HBjmev
via IFTTT

Roper Technologies Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, software developer Roper Technologies, Inc. (ROP) raised its adjusted earnings guidance for the full-year 2020, and provided adjusted earnings outlook for the fourth quarter, below analysts' estimates.

from RTT - Earnings https://ift.tt/31M5JA5
via IFTTT

AMD Updates Guidance; Q3 Profit Tops Estimates

AMD (AMD) said it now expects 2020 revenue to grow by approximately 41 percent compared to 2019, up from prior guidance of 32 percent. Non-GAAP gross margin is expected to be approximately 45 percent, consistent with prior guidance.

from RTT - Earnings https://ift.tt/37FBHlw
via IFTTT

Cummins Expects Q4 Revenues To Be Similar To Q3 Levels - Quick Facts

While reporting its financial results for the third quarter on Tuesday, Cummins Inc. (CMI) said it currently expects fourth-quarter revenues to be similar to third quarter levels, with higher demand in North America truck markets and continued improvement in aftermarket sales, partially offset by lower demand in China. The company reported third-quarter revenues of $5.1 billion.

from RTT - Earnings https://ift.tt/2HIXayM
via IFTTT

Crocs Guides Q4, FY20 Revenue Growth Well Above Estimates - Quick Facts

While reporting financial results for the third quarter on Tuesday, casual footwear maker Crocs, Inc. (CROX) provided revenue growth outlook for the fourth quarter and full-year 2020, well above analysts' estimates.

from RTT - Earnings https://ift.tt/37QTWVj
via IFTTT

Old Dominion Freight Line Q3 Profit Rises, Results Beat View - Quick Facts

Old Dominion Freight Line Inc. (ODFL) on Tuesday reported third-quarter net income of $201.87 million or $1.71 per share, up from $164.10 million or $1.37 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2HB8kpA
via IFTTT

Xerox Holdings Q3 Profit Declines, But Results Top Estimates - Quick Facts

Workplace technology company Xerox Holdings Corp. (XRX) reported Tuesday that net income for the third quarter declined to $90 million or $0.41 per share from $221 million or $0.68 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/2J2KSSC
via IFTTT

Merck Updates FY20 Guidance; Q3 Profit Tops Estimates - Quick Facts

Merck (MRK) narrowed and raised its full-year 2020 non-GAAP earnings per share guidance range to be between $5.91 and $6.01, including a negative impact from foreign exchange of approximately 2.5% at mid-October exchange rates. The company narrowed and raised its full-year 2020 revenue outlook range to be between $47.6 billion and $48.6 billion, including a negative impact from foreign exchange of approximately 1.5% at mid-October exchange rates. Analysts polled by Thomson Reuters expect the company to report profit per share of $5.71 on revenue of $48 billion. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/3moD5Nq
via IFTTT

Pfizer Tightens FY20 Outlook Range; Q3 Adj. EPS Tops View - Quick Facts

While reporting financial results for the third quarter on Tuesday, Pfizer Inc. (PFE) tightened its full-year 2020 guidance range for adjusted earnings and revenues. However, the company reaffirmed all 2020 financial guidance components for New Pfizer and Upjohn.

from RTT - Earnings https://ift.tt/2HD3sAw
via IFTTT

Eli Lilly Q3 Profit Misses Estimates; Revenue Up 5%

Eli Lilly and Company (LLY) said it delivered solid financial results in the third quarter, as the company's key growth products continued to be the catalyst for volume-based revenue growth. On a non-GAAP basis, earnings per share increased 4 percent. Revenue rose 5 percent driven by volume growth of 9 percent. The company reaffirmed its earnings per share guidance for 2020 on a non-GAAP basis.

from RTT - Earnings https://ift.tt/37S3SNY
via IFTTT

3M Expects October Sales To Be Flat To Up Slightly - Quick Facts

While reporting financial results for the third quarter on Tuesday, 3M Co. (MMM) said its guidance for the full-year 2020 remains withdrawn as it is not able to estimate the full duration, magnitude and pace of recovery across its diverse end markets with reasonable accuracy, due to the continued evolving and uncertain impact of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3ouFI24
via IFTTT

Pre-market Movers In Healthcare Sector: ALKS, ETTX, VXRT, CATB, GNFT...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/31Mhd6C
via IFTTT

Centene Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, healthcare company Centene Corp. (CNC) raised its earnings, adjusted earnings and revenue guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/35H944C
via IFTTT

This Week's Healthcare IPOs

In the healthcare sector, 17 companies have made their debut on the NASDAQ so far this month. Let's take a look at the U.S. healthcare IPOs scheduled for the week.

from RTT - Biotech https://ift.tt/3kzn2Ma
via IFTTT

HSBC Q3 Results Down, Expects To Beat Cost Target; Stock Up

Asia-focused lender HSBC Holdings Plc reported Tuesday weak profit and revenues in its third quarter, while adjusted deposits increased from the previous year. Further, the company accelerated its restructuring plan, expecting to beat its Group cost target of =$31 billion in 2022. HSBC shares were gaining around 5 percent in Hong Kong trading.

from RTT - Earnings https://ift.tt/3opQruN
via IFTTT

ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz

Today's Daily Dose brings you news about the amended immuno-oncology collaboration agreement between AnaptysBio and GlaxoSmithKline, BioSig discontinuing its phase II trial of investigational antiviral Merimepodib in COVID-19, the failure of Catabasis' phase III trial of Edasalonexent in Duchenne muscular dystrophy, and Mirati's promising early data of Adagrasib in lung cancer.

from RTT - Biotech https://ift.tt/34uhQna
via IFTTT

Stock Alert: SAP Tumbles 21% After Cutting FY20 Revenue Outlook

Shares of SAP SE (SAP) are falling more than 21 percent or $32.26 in Monday's morning trade at $117.42 after the German software major lowered its revenue forecast for fiscal 2020.

from RTT - Earnings https://ift.tt/2HtaXtX
via IFTTT

Futures Pointing To Initial Weakness On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Monday, with stocks likely to move to the downside following the mixed performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/3kwl7YV
via IFTTT

FDA Delays Decision On Spectrum's Neutropenia Drug Due To COVID-19 Related Travel Restrictions

The FDA has decided to delay its decision on Spectrum Pharmaceuticals' (SPPI) Rolontis, which was due on October 24, as the regulatory agency has been unable to conduct inspection of the drug substance manufacturing facility due to COVID-19 related travel curbs.

from RTT - Biotech https://ift.tt/31IMGXI
via IFTTT

Hasbro Q3 Results Top Estimates - Quick Facts

Toy and board game company Hasbro, Inc. (HAS) reported Monday net earnings attributable to Hasbro for the third quarter of $220.90 million or $1.61 per share, compared to pro forma net earnings of $216.5 million or $1.57 per share in the year-ago period.

from RTT - Earnings https://ift.tt/34tWpCV
via IFTTT

Pre-market Movers In Healthcare Sector: ALRN, SELB, CODX, IPHA, NNOX.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2J1Sipb
via IFTTT

Biotech Stocks Facing FDA Decision In November 2020

On October 22, the FDA approved Gilead's (GILD) Veklury (remdesivir), the first drug for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Let's take a look at the companies that await a ruling from the FDA in November.

from RTT - Biotech https://ift.tt/2HADwFr
via IFTTT

Stock Alert: CLPS Jumps 40% On Reporting Profit

Shares of CLPS Inc. (CLPS) jumped nearly 40% on Friday morning after the company swung to a profit for the second-half of 2020.

from RTT - Earnings https://ift.tt/37zC54X
via IFTTT

Stock Alert: Triton International Rises 7% After Q3 Earnings Beat View

Shares of Triton International Limited (TRTN), a company engaged in the leasing and sale of intermodal containers, are gaining almost 7 percent or $2.49 in Friday's morning trade at $39.15, after the company's third-quarter earnings beat analysts' estimates.

from RTT - Earnings https://ift.tt/37z3X9j
via IFTTT

Stock Alert: Socket Mobile Soars 160% On Quarterly Results

Shares of nano-cap company Socket Mobile, Inc. (SCKT) are skyrocketing after the maker of barcode scanners reported a huge growth in profit for the third quarter.

from RTT - Earnings https://ift.tt/34mlFux
via IFTTT

FDA OKs Gilead's Remdesivir As First COVID-19 Treatment Despite WHO Findings

The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury.

from RTT - Biotech https://ift.tt/3ok9pTp
via IFTTT

Wall Street May Continue To Benefit From Optimism About Stimulus

The major U.S. index futures are currently pointing to a higher open on Friday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/3dQtR9G
via IFTTT

American Express Q3 Earnings Miss Estimates, But Revenues Top - Quick Facts

Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2HuqeKB
via IFTTT

Pre-market Movers In Healthcare Sector: SAVA, KTOV, PRVL, IMMP, GILD, ITRM, BBI.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2Hsu8nl
via IFTTT

Daimler Q3 Profit Climbs, Now Sees Flat EBIT In FY20; Stock Up

Shares of Daimler AG were gaining around 2 percent in the morning trading in Germany after the auto giant reported Friday higher profit in its third-quarter, despite weakness in revenues and sales volume. Further, the company now expects Group EBIT for full year 2020 at the prior-year level, compared to previous expectation of a decline.

from RTT - Earnings https://ift.tt/31uN2B1
via IFTTT

First American Financial Q3 Profit Declines, Revenue Rises - Quick Facts

First American Financial Corp. (FAF), a provider of title insurance, settlement services and risk solutions for real estate transactions, reported Thursday that its net income for the third quarter declined to $182.3 million or $1.62 per share, from $187.2 million or $1.65 per share in the year-ago period.

from RTT - Earnings https://ift.tt/31sXLMc
via IFTTT

Traders Looking For More Signs Of Progress Toward Stimulus Bill

The major U.S. index futures are pointing to a modestly lower open on Thursday following the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2IS9MnX
via IFTTT

Webster Financial Q3 Profit Declines - Quick Facts

Webster Financial Corp. (WBS), the holding company for Webster Bank, N.A. and its HSA Bank division, on Thursday reported third-quarter earnings applicable to common shareholders of $66.9 million or $0.75 per share, down from $91.4 million or $1.00 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3jjezLJ
via IFTTT

Nucor Expects Higher Earnings In Q4 Sequentially - Quick Facts

While reporting its financial results for the third quarter on Thursday, steel and steel products maker Nucor Corp. (NUE) said it expects higher earnings in the fourth quarter as compared to the third quarter of 2020, due primarily to positive pricing momentum in sheet and plate markets.

from RTT - Earnings https://ift.tt/31uitLy
via IFTTT

Watsco Q3 Profit Rises, Results Beat Estimates - Quick Facts

Watsco, Inc. (WSO), a distribution network for heating, air conditioning and refrigeration products, on Thursday reported an increase in third-quarter earnings allocated to shareholders to $97.35 million or $2.76 per share, from $76.51 million or $2.20 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3dQwt7i
via IFTTT

Reliance Steel & Aluminum Guides Q4 Adj EPS Below Estimates - Quick Facts

While reporting financial results for the third quarter on Thursday, metals service center company Reliance Steel & Aluminum Co. (RS) said it expects adjusted earnings for the fourth quarter in a range of $1.30 to $1.40 per share, as the company expects its average selling price per ton sold for the fourth quarter to be flat to up 2.0 percent sequentially.

from RTT - Earnings https://ift.tt/31vBdul
via IFTTT

Rogers Communications Q3 Profit Declines, But Results Beat View - Quick Facts

Canadian technology and media company Rogers Communications Inc. (RCI, RCI.TO) on Thursday reported a decrease in net income for the third quarter to C$512 million or C$1.01 per share from C$593 million or C$1.14 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2IWDh8f
via IFTTT

Pool Raises FY20 Earnings Outlook - Quick Facts

While reporting financial results for the thirdd quarter on Thursday, swimming pool distributor Pool Corp. (POOL) raised its earnings and adjusted earnings guidance for the full-year 2020, based on its results to date and expectations for the remainder of the year.

from RTT - Earnings https://ift.tt/2TiPRR0
via IFTTT

AT&T Q3 Adj. EPS Meets Estimates, Revenues Top

Telecom giant AT&T, Inc. reported Thursday a 24 percent decline in profit for the third quarter, primarily hurt by lower revenues across all its operating segments amid the impact from COVID-19 pandemic. Adjusted earnings for the quarter met analysts' expectations, while quarterly revenues topped their estimates.

from RTT - Earnings https://ift.tt/3dNYpZw
via IFTTT

AstraZeneca Covid-19 Vaccine Trial In Brazil To Continue Despite Volunteer's Death

A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, has died, Brazilian health authority Anvisa said. Oxford university reportedly confirmed the plan to continue the trial after careful assessment that there have been no concerns about safety of the clinical trial.

from RTT - Biotech https://ift.tt/3jeHa4U
via IFTTT

Pre-market Movers In Healthcare Sector: CBLI, DARE, NEOS, APTX, CHEK...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2Tgb1zl
via IFTTT

Tractor Supply Guides Q4 EPS, Net Sales Above Estimates - Quick Facts

While reporting financial results for the third quarter on Thursday, rural lifestyle retailer Tractor Supply Co. (TSCO) provided earnings and net sales guidance for the fourth quarter.

from RTT - Earnings https://ift.tt/3oardQZ
via IFTTT

Danaher Guides Q4 Revenue Growth Below Estimates - Quick Facts

While reporting financial results for the third quarter on Thursday, medical company Danaher Corp. (DHR) said it anticipates adjusted core revenue growth for the fourth quarter, including Cytiva, to be in the low-double digit range.

from RTT - Earnings https://ift.tt/2TtFrOR
via IFTTT

Allegion Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, security products and solutions provider Allegion plc (ALLE) raised its earnings and revenue growth guidance for the full year 2020.

from RTT - Earnings https://ift.tt/37qmlkK
via IFTTT

Competition watchdog blocks Viagogo's $4bn takeover of StubHub

Regulator says deal between controversial ticket resale firms would harm consumers

The takeover of ticket resale website StubHub by its rival Viagogo has been provisionally blocked by the competition watchdog, throwing the future of the controversial $4bn tie-up into doubt.

The Competition and Markets Authority (CMA) said Viagogo, which pressed ahead with the deal despite a warning from the watchdog, must now address its concerns, potentially by selling all or part of StubHub.

Related: 170,000 jobs in UK's live music sector 'will be lost by Christmas'

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2HnKFZR

CRSP Reports CARBON Trial Data, NK's COVID-19 Vaccine Study Chugs Along, ZSAN Slips As FDA Says "No"

Today's Daily Dose brings you news about FDA denying approval to Zosano Pharma's migraine treatment; CRISPR Therapeutics' CARBON trial results; and the progress in NantKwest's COVID-19 vaccine candidate.

from RTT - Biotech https://ift.tt/3mbNXhs
via IFTTT

Stock Alert: Calix Surges To New 52-week High

Shares of Calix, Inc. (CALX) a provider of cloud and software platforms, are gaining more than 26 percent or $5.53 in Wednesday's morning trade at $26.65, after touching a new 52-week high of $27.78 as the company's third-quarter results beat analysts' expectations and it also provided outlook for the fourth quarter above estimates.

from RTT - Earnings https://ift.tt/37wMnTl
via IFTTT

Stock Alert: AutoNation Hits New 52-week High

Shares of AutoNation Inc. (AN) are rising almost 8 percent or $5 in Wednesday's morning trade at $68.03, after touching a new 52-week high of $69.28 as the automotive retailer reported better-than-expected results for the third quarter and also increased its share repurchase authorization.

from RTT - Earnings https://ift.tt/2Tec0jw
via IFTTT

Uncertainty About Stimulus May Lead To Choppy Trading On Wall Street

The major U.S. index futures are pointing to a roughly flat open on Wednesday, with stocks likely to show a lack of direction after ending the previous session modestly higher.

from RTT - Market Analysis https://ift.tt/2Tditv3
via IFTTT

Amphenol Reinstates FY20 Outlook Above View; Boosts Qtly. Dividend 16% - Quick Facts

While reporting financial results for the third quarter on Wednesday, Amphenol Corp. (APH) reinstated its earnings, adjusted earnings and sales guidance for the full-year 2020, above analysts' expectations. It also provided outlook for the fourth quarter and raised quarterly dividend 16 percent.

from RTT - Earnings https://ift.tt/35ixrWm
via IFTTT

Verizon Q3 Profit Tops Estimates, Operating Revenue Down 4.1%; Raises Guidance

Verizon Communications Inc. (VZ) said the company delivered strong third quarter results with an increased cash flow, wireless service revenue growth, and the most Fios Internet net adds since fourth 2014. The company said its performance was highlighted by increases in wireless service revenue and total Fios Internet net additions. Also, the company revised earnings guidance upward for the year.

from RTT - Earnings https://ift.tt/35hilQM
via IFTTT

NextEra Energy Updates FY20, FY21 Adjusted Earnings Outlook - Quick Facts

While reporting its financial results for the third quarter on Wednesday, NextEra Energy, Inc. (NEE) said that due to the four-for-one stock split approved by its board in mid-September, it has updated its full-year adjusted earnings outlook ranges to reflect the increase in outstanding shares.

from RTT - Earnings https://ift.tt/3o9ksie
via IFTTT

Biogen Trims FY20 Earnings Outlook; Q3 Results Top Estimates - Quick Facts

While reporting financial results for the third quarter on Wednesday, Biogen Inc. (BIIB) trimmed its earnings, adjusted earnings and revenue guidance for the full-year 2020, due to the impact of multiple generic entrants for its multiple sclerosis drug Tecfidera in the U.S.

from RTT - Earnings https://ift.tt/2IUVy61
via IFTTT

Teledyne Technologies Raises FY20 Earnings Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, Teledyne Technologies Inc. (TDY) raised its earnings guidance for fiscal 2020 to a range of $9.70 to $10.00 per share from the prior forecast range of $9.45 to $10.00 per share.

from RTT - Earnings https://ift.tt/37tMwXQ
via IFTTT

Pre-market Movers In Healthcare Sector: ASTC, SELB, XERS, ADTX, ITRM...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3m5Fj4c
via IFTTT

FirstCash Says Full-year Retail Sales To Be Down Below 10% - Quick Facts

While reporting financial results for the third quarter on Wednesday, retail pawn stores operator FirstCash, Inc. (FCFS) said it has not reinstated earnings guidance for the balance of the year, given the ongoing uncertainties regarding the pace of the recovery in pawn receivables and inventories and ongoing currency volatility.

from RTT - Earnings https://ift.tt/2TfWQKF
via IFTTT

Futures Pointing To Higher Open On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday following the weakness seen in the previous session.

from RTT - Market Analysis https://ift.tt/34e1hf4
via IFTTT

Prologis Raises FY20 Outlook - Quick Facts

While reporting its financial results for the third quarter on Tuesday, Prologis Inc. (PLD) raised its earnings outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/3dIKdB7
via IFTTT

Albertsons Cos. Guides FY20 Adj. EPS Above Estimates - Quick Facts

While reporting financial results for the second quarter on Tuesday, food and drug retailer Albertsons Companies, Inc. (ACI) provided adjusted earnings and identical sales guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3j8VoEo
via IFTTT

ManpowerGroup Q3 Profit Declines, But Results Beat View - Quick Facts

ManpowerGroup, Inc. (MAN), a provider of workforce solutions and services, on Tuesday reported third-quarter net earnings of $10.3 million or $0.18 per share, down sharply from $146.1 million or $2.42 per share in the prior-year period.

from RTT - Earnings https://ift.tt/35aSTfO
via IFTTT

Lockheed Martin Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Lockheed Martin Corp. (LMT) raised its earnings and net sales outlook for the full-year 2020. The company also provided net sales guidance for the full-year 2021, below the current analysts' expectations.

from RTT - Earnings https://ift.tt/37smCDF
via IFTTT

Philip Morris Q3 Profit Tops Estimates; Net Revenues Down 1.5% On Organic Basis

Philip Morris International Inc. (PM) reported third quarter adjusted earnings per share of $1.42, down by 0.7% from prior year. Excluding currency, adjusted earnings per share was $1.51, up 5.6% from last year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $1.36, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2Tap2hZ
via IFTTT

Procter & Gamble Boosts FY21 Outlook As Q1 Results Top View

Consumer goods giant Procter & Gamble Co. on Tuesday reported a 19 percent increase in profit for the first quarter of fiscal 2021 from last year, driven by net sales growth across its operating segments and improved operating margin. Both revenue and core earnings per share for the quarter beat analysts' estimates. Looking ahead, the company raised its earnings and revenue growth guidance.

from RTT - Earnings https://ift.tt/3jd88Kg
via IFTTT

Pentair Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Pentair plc (PNR) raised its earnings, adjusted earnings and sales guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3oawqrO
via IFTTT

UBS Q3 Profit Nearly Doubles, Proposes Dividend; Stock Up

Shares of UBS Group AG were gaining around 3 percent in Swiss trading after the banking major reported Tuesday that its third-quarter profit nearly doubled mainly driven by ongoing strong client activity. The company said its profit before tax was the best third-quarter result in a decade. Further, the bank proposed dividend.

from RTT - Earnings https://ift.tt/2IN8wCG
via IFTTT

Dover Boosts FY20 Earnings Guidance - Quick Facts

While reporting financial results for the third quarter on Tuesday, diversified manufacturer Dover Corp. (DOV) raised its earnings and adjusted earnings guidance for the full-year 2020, based on the improved operating results in the third quarter and a healthy order backlog.

from RTT - Earnings https://ift.tt/35dYj9L
via IFTTT

Pre-market Movers In Healthcare Sector: ACOR, APTX, CARA, CBLI, IVA, ISR.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/37mDVG6
via IFTTT

Commerce Bancshares Q3 Results Top Estimates - Quick Facts

Commerce Bancshares, Inc. (CBSH) reported Tuesday net income attributable to Commerce Bancshares for the third quarter of $132.4 million or $1.11 per share, higher than $109.2 million or $0.93 per share last year.

from RTT - Earnings https://ift.tt/3dINW1N
via IFTTT

ABBV Seeks Expanded Approval Of Rinvoq, APTX Cheered By PTSD Data, ENDP Snaps Up BSTC, LQDA On Watch

Today's Daily Dose brings you news about AbbVie seeking expanded approval of RINVOQ in atopic dermatitis, Aptinyx's positive results in post-traumatic stress disorder trial, Endo International acquiring BioSpecifics Technologies, the merger agreement between Cleveland BioLabs and privately-held Cytocom, and the licensing agreement offer of Liquidia.

from RTT - Biotech https://ift.tt/3kfozXI
via IFTTT

Persistent Stimulus Optimism May Lead To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to move to the upside following the mixed performance seen last Friday.

from RTT - Market Analysis https://ift.tt/357Rx5s
via IFTTT

Lennox International Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Monday, Lennox International Inc. (LII) raised its earnings and revenue growth outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/3o5Ejis
via IFTTT

Halliburton Slips To Loss In Q4 - Quick Facts

Halliburton Co. (HAL) reported Monday a fourth-quarter net loss attributable to company of $17 million or $0.02 per share, compared to net income of $295 million or $0.34 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3j8GEFr
via IFTTT

Pre-market Movers In Healthcare Sector: MTP, FLDM, RDHL, ENLV, TRIB, RWLK...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2T6Ri51
via IFTTT

Calliditas Therapeutics: On The Watch For Nefigard Data

Shares of Calliditas Therapeutics AB (CALT) have gained nearly 21% so far this month, as the company gears up for a clinical trial catalyst this quarter.

from RTT - Biotech https://ift.tt/359j2eU
via IFTTT

Philips Q3 Profit Up, Orders Down; Sees Sales Growth In FY20, Ahead; Stock Up

Shares of Philips Electronics NV were gaining around 2 percent in the morning trade in Amsterdam after the Dutch consumer electronics giant reported Monday higher profit in its third quarter, despite drop in comparable order intake. For the full year 2020, the company continues to expect to deliver modest comparable sales growth, with an adjusted EBITA margin of around the level of last year.

from RTT - Earnings https://ift.tt/37ldDEs
via IFTTT

This Day That Year: Innate Pharma (IPHA)

Shares of Innate Pharma S.A. (IPHA) are down nearly 50 percent from their 52-week high of $8.24, recorded in January of this year, and trade around $4.

from RTT - Biotech https://ift.tt/358PLkz
via IFTTT

Medicenna Gets FDA Go-Ahead To Proceed With Phase 3 Study Of MDNA55 In Recurrent Glioblastoma

Medicenna Therapeutics Corp. (MDNA) (MDNA.TO) has been advised to proceed with a hybrid phase III registration trial of MDNA55 in recurrent glioblastoma, following a recent End of phase II meeting with the FDA.

from RTT - Biotech https://ift.tt/34ZBnLo
via IFTTT

Upbeat Retail Sales Data May Generate Early Buying Interest

The major U.S. index futures are currently pointing to a higher open on Friday, with stocks likely to regain ground after moving lower over the three previous sessions.

from RTT - Market Analysis https://ift.tt/3nZQI7e
via IFTTT

Novartis Gets Positive CHMP Opinion For Leqvio For Patients With Hypercholesterolemia - Quick Facts

Swiss drug major Novartis AG (NVS) announced Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing authorization of Leqvio (inclisiran) for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

from RTT - Biotech https://ift.tt/3j2myN5
via IFTTT

VF Corp. Guides FY21 Above Estimates - Quick Facts

While reporting financial results for the second quarter on Friday, VF Corp. (VFC) provided adjusted earnings and revenue guidance for the full-year 2021, above analysts' expectations.

from RTT - Earnings https://ift.tt/3lQkucS
via IFTTT

Pre-market Movers In Healthcare Sector: RWLK, ETTX, AMRN, CEMI...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/343vg9N
via IFTTT

SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch

Today's Daily Dose brings you news about Eiger BioPharma's COVID-19 ILIAD study results, disappointing results of Servier/Galapagos' knee osteoarthritis drug trial, Anavex Life's Parkinson's disease dementia trial, the progress in Sanofi/Translate Bio's COVID-19 vaccine candidate MRT5500, and Lilly loosening its purse strings to bolster its pipeline with SARM1 programs for axonal degeneration.

from RTT - Biotech https://ift.tt/31auo10
via IFTTT

Volvo Group Q3 Adj. Operating Income Declines; Adj. Net Sales Down 16%

Volvo Group reported that its third quarter net income to owners declined year-on-year to 5.72 billion Swedish kronor from 7.45 billion kronor, last year. Earnings per share was 2.81 kronor compared to 3.67 kronor. Adjusted operating income was 7.22 billion kronor compared to 10.89 billion kronor, previous year. The Group said the the lower adjusted operating income year-over-year is mainly an effect of reductions in vehicle volumes and lower capacity utilization in the industrial system, which were partly offset by good cost execution across the Group.

from RTT - Earnings https://ift.tt/3dE2KPa
via IFTTT

Stimulus Uncertainty, Renewed Coronavirus Concerns May Weigh On Wall Street

The major U.S. index futures are pointing to a sharply lower open on Thursday, with stocks likely to extend the downward move seen over the two previous sessions.

from RTT - Market Analysis https://ift.tt/354QIul
via IFTTT

Stock Alert: Aurora Mobile Shares Rise 10% In Premarket

Shares of Aurora Mobile Ltd. (JG) are rising over 10% in pre-market today, after the company announced that its development and commercialization project relating to a deep learning and big data-powered system will receive special support funding of RMB17.24 million from the Development and Reform Commission of Shenzhen Municipality or Shenzhen DRC, representing the highest allocation among all recipients.

from RTT - Before the Bell https://ift.tt/373LNMK
via IFTTT

Morgan Stanley Q3 Profit Up 26%; Results Top Estimates

Financial services firm Morgan Stanley reported Thursday a profit for the third quarter that increased 26 percent from last year, reflecting 16 percent revenue growth amidst strength across all business segments. Both adjusted earnings per share and quarterly net revenues topped analysts' expectations.

from RTT - Earnings https://ift.tt/2SYRUtj
via IFTTT

Stock Alert: Staffing 360 Solutions Shares Surge 113% In Early Trade

Shares of Staffing 360 Solutions Inc. (STAF) are soaring over 113% in pre-market today on no news. The stock has been trading in the range of $0.28 - $1.40 for the past one year, and closed Wednesday's trade at $0.79, up 15 cents or 23.78%. Trading volume was over 10.6 million versus an average volume of 394K shares.

from RTT - Before the Bell https://ift.tt/3lOvRlv
via IFTTT

Pre-market Movers In Healthcare Sector: ORGO, NMRD, NK, CYCN...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3lOj6HB
via IFTTT

Healthcare IPOs For Oct 16

The number of healthcare firms that have gone public on the U.S. stock exchanges so far this month is 9. Let's take a look at the IPOs scheduled for tomorrow.

from RTT - Biotech https://ift.tt/2GRwhZL
via IFTTT

FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade

Today's Daily Dose brings you news about AnaptysBio's generalized pustular psoriasis trial results, Cyclerion discontinuing its Sickle Cell Disease drug program, FDA approving the first drug for Ebola, analyst's new price target of Replimune stock, and Vertex halting its phase II study of VX-814 in patients with alpha-1 antitrypsin deficiency.

from RTT - Biotech https://ift.tt/2Fvbc6x
via IFTTT

CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch

Today's Daily Dose brings you news about the third-quarter preliminary revenue results of CareDx and Ocular Therapeutix; Lilly pursuing emergency use authorization for LY-CoV555 in high-risk COVID-19 patients, and dual government support for TLC in developing a COVID-19 therapy.

from RTT - Biotech https://ift.tt/3nNigwE
via IFTTT

Meijer Recalls Cantaloupes For Salmonella Concerns

Meijer, a privately-owned retailer, is recalling whole cantaloupe and select cut cantaloupe fruit trays and bowls citing potential risk of Salmonella that causes foodborne illness, according to the Food and Drug Administration. The multi-state recall involves Meijer Brand cantaloupes, as well as Kandy Brand cantaloupes from Aguila, Arizona-based Eagle Produce, LLC.

from RTT - Biotech https://ift.tt/34Uz3oV
via IFTTT

JPMorgan Chase & Co. Q3 Profit Tops Estimates

JPMorgan Chase & Co. (JPM) reported third quarter earnings per share of $2.92 compared to $2.68, a year ago. The company noted that its third quarter results included $524 million of firmwide legal expense, $0.17 decrease in earnings per share. On average, 23 analysts polled by Thomson Reuters expected the company to report profit per share of $2.23, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/34R22tM
via IFTTT

Johnson & Johnson Q3 Results Top Estimates; Boosts FY20 Outlook

Healthcare company Johnson & Johnson on Tuesday reported that its profit for third quarter that more than doubled from last year, powered by better-than-expected procedure recovery in medical devices, growth in consumer health, and continued strength in pharmaceuticals. Both adjusted earnings per share and revenues topped analysts' expectations.The company also boosted its full-year 2020 outlook.

from RTT - Earnings https://ift.tt/374Ajs8
via IFTTT

IBM To Focus On Open Hybrid Cloud Platform; To Spin-Off Managed Infrastructure Services Unit

IBM (IBM) announced the company will separate its Managed Infrastructure Services unit of its Global Technology Services division into a new public company. Going forward, IBM will focus on its open hybrid cloud platform. The new company will be entirely focused on managing and modernizing client-owned infrastructures. The separation is anticipated to be achieved as a tax-free spin-off to shareholders, and completed by the end of 2021.

from RTT - Earnings https://ift.tt/375bo88
via IFTTT

Samsung Sees 58% Rise In Q3 Operating Profit

Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its third-quarter operating profit will rise about 58.10 percent from last year. It projects sales will increase 6.45 percent. The company's mobile and chip businesses benefited from U.S. restrictions on Huawei Technologies Co.

from RTT - Earnings https://ift.tt/2IrqI4A
via IFTTT

Pfizer Says PENELOPE-B Trial Of IBRANCE Did Not Meet Primary Endpoint - Quick Facts

The German Breast Group (GBG) and Pfizer Inc. (PFE) announced Friday that the collaborative Phase 3 PENELOPE-B trial of IBRANCE (palbociclib) in Early Breast Cancer did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in women with hormone receptor-positive (HR+), human epidermal growth factor-negative (HER2-) early breast cancer (eBC) who have residual invasive disease after completing neoadjuvant chemotherapy. No unexpected safety signals were observed.

from RTT - Biotech https://ift.tt/3nFl2E6
via IFTTT

Stock Alert: InMode Climbs 11% On Upbeat Outlook

Shares of InMode Ltd. (INMD) are rising more than 11 percent or $4.33 in Tuesday's morning trade at $43.46 after the Israel-based medical technology company provided its financial outlook for the third quarter as well as raised its revenue outlook for fiscal 2020 above analysts' estimates.

from RTT - Earnings https://ift.tt/3nGJ0Pv
via IFTTT

Delta Air Lines Slips To Loss In Q3, Results Miss View - Quick Facts

Delta Air Lines, Inc. (DAL) on Tuesday reported a net loss for the third quarter on a 76 percent plunge in revenues that reflected weak demand for air travel due to the impact of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2GTG7Ky
via IFTTT

Spotlight Shifts To Corporate News Amid Impasse On Stimulus Bill

The major U.S. index futures are currently pointing to a mixed open on Tuesday, as the Dow futures are notably lower but the Nasdaq futures are sharply higher.

from RTT - Market Analysis https://ift.tt/3nOLnzw
via IFTTT

Celldex Therapeutics Says First Patient Dosed In Phase 1b Study Of CDX-0159 - Quick Facts

Celldex Therapeutics Inc. (CLDX) said Tuesday that enrollment has opened and the first patient has been dosed in its randomized, double-blind Phase 1b study of CDX-0159 in patients with chronic spontaneous urticaria (CSU).

from RTT - Biotech https://ift.tt/3lLyW63
via IFTTT

Pre-market Movers In Healthcare Sector: SELB, GNMK, IMRN, AGE, ACHV.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/370VlYP
via IFTTT

JPMorgan Chase & Co. Q3 Profit Tops Estimates

JPMorgan Chase & Co. (JPM) reported third quarter earnings per share of $2.92 compared to $2.68, a year ago. The company noted that its third quarter results included $524 million of firmwide legal expense, $0.17 decrease in earnings per share. On average, 23 analysts polled by Thomson Reuters expected the company to report profit per share of $2.23, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/3iUX1pd
via IFTTT

Johnson & Johnson Q3 Results Top Estimates; Boosts FY20 Outlook

Healthcare company Johnson & Johnson on Tuesday reported that its profit for third quarter that more than doubled from last year, powered by better-than-expected procedure recovery in medical devices, growth in consumer health, and continued strength in pharmaceuticals. Both adjusted earnings per share and revenues topped analysts' expectations.The company also boosted its full-year 2020 outlook.

from RTT - Earnings https://ift.tt/3lGFHWx
via IFTTT

Pre-market Movers In Healthcare Sector: EARS, ALT, IVA, ENLV, EBS...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2Fpmr0h
via IFTTT

This Week's Healthcare IPOs

There have been 8 IPOs in the healthcare sector so far this month in the U.S. stock market. Listed below are the healthcare companies that are going public this week.

from RTT - Biotech https://ift.tt/3lCQm4H
via IFTTT

ATXI Plunges On Thumbs-down, VYGR's Huntington's Disease Trial On Hold, Deal Or No Deal For SURF?

Today's Daily Dose brings you news about FDA declining approval for Avenue Therapeutics/Fortress Biotech's pain drug IV Tramadol, encouraging data from Gilead/ Galapagos' Ulcerative Colitis trial, reports of Surface Oncology receiving a takeover offer from GlaxoSmithKline, and clinical hold slapped by the FDA on Voyager's Huntington's disease trial.

from RTT - Biotech https://ift.tt/2GZyIco
via IFTTT

Traders Remain Optimistic About Stimulus Bill Despite Impasse

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to add to the strong gains posted last week.

from RTT - Market Analysis https://ift.tt/3iQQs74
via IFTTT

Pre-market Movers In Healthcare Sector: IMRN, AKBA, MDGS, ENLV...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/30XCs5n
via IFTTT

Growing NeXT: Personalis (PSNL) Hits All-Time High

Shares of Personalis Inc. (PSNL) closed at an all-time high of $30.52 on Friday (Oct.9, 2020) and that reflects a gain of over 140 percent in 3.5 months after our stock alert.

from RTT - Biotech https://ift.tt/34MeomV
via IFTTT

Stock Alert: MicroVision Shares Up 20% In Premarket

Shares of MicroVision Inc. (MVIS) are surging over 20% in pre-market today on no news. The stock has been trading in the range of $0.15 - $3.45 for the past one year, and closed Thursday's trade at $2.24, up 12 cents or 5.66%. Trading volume was over 11.3 million versus an average volume of 9.39 million shares.

from RTT - Before the Bell https://ift.tt/3nC8T30
via IFTTT

Stock Alert: Medigus Shares Surge 35% In Early Trade

Shares of the medical devices company Medigus Ltd. (MDGS) are soaring over 35% in pre-market today, after the company announced a definitive agreement to acquire a controlling interest in Smart Repair Pro Inc. and Purex Inc., two data-driven e-commerce companies, operating on the Amazon Marketplace.

from RTT - Before the Bell https://ift.tt/3iNsJEy
via IFTTT

Futures Pointing To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Friday, with stocks likely to extend the upward move seen over the two previous sessions.

from RTT - Market Analysis https://ift.tt/3jMro23
via IFTTT

Pfizer Says PENELOPE-B Trial Of IBRANCE Did Not Meet Primary Endpoint - Quick Facts

The German Breast Group (GBG) and Pfizer Inc. (PFE) announced Friday that the collaborative Phase 3 PENELOPE-B trial of IBRANCE (palbociclib) in Early Breast Cancer did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in women with hormone receptor-positive (HR+), human epidermal growth factor-negative (HER2-) early breast cancer (eBC) who have residual invasive disease after completing neoadjuvant chemotherapy. No unexpected safety signals were observed.

from RTT - Biotech https://ift.tt/30M6oRy
via IFTTT

Pre-market Movers In Healthcare Sector: SELB, GNMK, IMRN, AGE, ACHV.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/34EmYUT
via IFTTT

Optimism About Stimulus May Lead To Continued Strength On Wall Street

The major U.S. index futures are pointing to a higher open on Thursday, with stocks likely to add to the strong gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/3nv5OBK
via IFTTT

IBM To Focus On Open Hybrid Cloud Platform; To Spin-Off Managed Infrastructure Services Unit

IBM (IBM) announced the company will separate its Managed Infrastructure Services unit of its Global Technology Services division into a new public company. Going forward, IBM will focus on its open hybrid cloud platform. The new company will be entirely focused on managing and modernizing client-owned infrastructures. The separation is anticipated to be achieved as a tax-free spin-off to shareholders, and completed by the end of 2021.

from RTT - Earnings https://ift.tt/3lnE3ZS
via IFTTT

TalkTalk agrees to discuss £1.1bn takeover bid

Shares surge after news of hedge fund interest in buying UK’s fourth-largest broadband provider

Shares in Charles Dunstone’s TalkTalk surged by 16% after the telecoms company agreed to discuss a £1.1bn takeover bid.

The bid has come from Toscafund, the telecoms company’s second-largest shareholder. The TalkTalk board have agreed to negotiations but the hedge fund would have to get the backing of executive chairman and founder, Dunstone.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2GO9RIa

CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch

Today's Daily Dose brings you news about the third-quarter preliminary revenue results of CareDx and Ocular Therapeutix; Lilly pursuing emergency use authorization for LY-CoV555 in high-risk COVID-19 patients, and dual government support for TLC in developing a COVID-19 therapy.

from RTT - Biotech https://ift.tt/2GJyfuP
via IFTTT

Healthcare IPOs For October 9

We are just days into the final quarter of the year. The number of healthcare firms that have gone public on the U.S. stock exchanges so far this month is 4. Let's take alook at the IPOs scheduled for Friday (Oct 9).

from RTT - Biotech https://ift.tt/2Sy4Ypz
via IFTTT

Stock Alert: Levi Strauss Rises 9% After Quarterly Results Beat Estimates

Shares of Levi Strauss & Co. (LEVI) are climbing more than 9 percent or $1.36 in Wednesday's morning trade at $16.10, after the apparel retailer reported results for the third quarter that beat analysts' expectations.

from RTT - Earnings https://ift.tt/3d51t3l
via IFTTT

Opdivo Plus Chemotherapy As Neoadjuvant Treatment In Resectable NSCLC Trial Hits Key Goal, Says BMY

Bristol Myers Squibb's (BMY) phase III study investigating its blockbuster drug Opdivo in combination with chemotherapy as *neoadjuvant treatment of resectable non-small cell lung cancer, dubbed CheckMate 816, has met the primary endpoint of pathologic complete response.

from RTT - Biotech https://ift.tt/33DseZF
via IFTTT

U.S. Stocks May Regain Ground After Trump Urges Individual Stimulus Measures

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to regain ground following the sell-off seen late in the previous session.

from RTT - Market Analysis https://ift.tt/3iynFnu
via IFTTT

Stock Alert: Hill International Shares Up 22% In Premarket

Shares of Hill International Inc. (HIL) are currently trading at $1.92, up 35 cents or 22.29% in pre-market today.

from RTT - Before the Bell https://ift.tt/2F9x9rN
via IFTTT

RPM International Guides Q2 Net Sales Growth Below Estimates - Quick Facts

While reporting financial results for the first quarter of fiscal 2021 on Wednesday, RPM International Inc. (RPM) provided sales growth guidance for the second quarter. The company also maintained its previously provided directions for the full-year 2021.

from RTT - Earnings https://ift.tt/2SxfaOP
via IFTTT

Pre-market Movers In Healthcare Sector: MDGS, PSTI, CDXC, ENLV, CTIC...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2GHhHDy
via IFTTT

AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Track

Today's Daily Dose brings you news about Axovant Gene's Parkinson's disease trial results, Corbus Pharma's cystic fibrosis trial data, Gamda's progress with Omidubicel, an investigational advanced cell therapy designed to enhance the life-saving benefits of bone marrow transplant, Merck KGa's out-licensing agreement with Novartis, and Santhera dumping DMD drug program Puldysa, among others.

from RTT - Biotech https://ift.tt/3nk7H45
via IFTTT

Stock Alert: TransAct Technologies Jumps 20% After Lifting Q3 Outlook

Shares of TransAct Technologies Inc. (TACT) is gaining nearly 20% on Tuesday morning after the computer hardware company lifted its third-quarter revenue outlook.

from RTT - Earnings https://ift.tt/30Gbm2t
via IFTTT

FDA Proposes Withdrawal Of AMAG's Preterm Birth Drug Makena, Generics From Market

The FDA is proposing to withdraw AMAG Pharmaceuticals Inc.'s (AMAG) preterm birth drug Makena from the market because the required postmarket study failed to verify the clinical benefit of the drug.

from RTT - Biotech https://ift.tt/33xxxtw
via IFTTT

Seneca Recalls Cinnamon Apple Chips For Salmonella Concerns

Washington-based Seneca Snack Co. is recalling cinnamon flavor apple chips citing possible Salmonella contamination, the U.S. Food and Drug Administration said in a statement. The recall involves Seneca Cinnamon Apple Chips 0.7 ounce Package and 2.5 ounce Package with Individual Package Codes of 26JUN2021 and 28JUN2021, respectively. The company is also calling back Clancy's Cinnamon Apple Chips.

from RTT - Biotech https://ift.tt/36Im6Bj
via IFTTT

Corbus Pharma Says Phase 2b Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Facts

Corbus Pharmaceuticals Holdings, Inc. (CRBP) announced Tuesday that the CF-002 Phase 2b study of lenabasum in patients with cystic fibrosis (CF) did not meet the primary endpoint of a statistically significant reduction in rate of new pulmonary exacerbations (PEx) per subject per 28 weeks.

from RTT - Biotech https://ift.tt/3ljIWTH
via IFTTT

Pre-market Movers In Healthcare Sector: XTNT, BNTX, GLYC, ALNA, MGEN, IOVA, ARTL.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3jH2O2U
via IFTTT

GSK, AZN 1st To Use NVDA's Supercomputer, IOVA To Delay BLA Filing, YMAB Plunges, GLYC On Watch

Today's Daily Dose brings you news about Eidos' merger with BridgeBio, the first pharmaceutical companies that will make use of the most powerful supercomputer, known as "Cambridge-1", the FDA granting Rare Pediatric Disease Designation to GlycoMimetics' sickle cell disease drug candidate, and the delay in filing of Lifileucel BLA by Iovance, among others.

from RTT - Biotech https://ift.tt/3nou3Be
via IFTTT

Positive Reports About Trump's Health May Generate Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to move back to the upside following the weakness seen in the previous session.

from RTT - Market Analysis https://ift.tt/2GpAGmc
via IFTTT

Pre-market Movers In Healthcare Sector: ENLV, CHFS, EVGN, SLDB, CTIC, VXRT.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2SuKygV
via IFTTT

Various Cut, Sliced Fruits Sold By Walmart Recalled For Listeria Concerns

Country Fresh has recalled various cut and sliced fruits distributed mainly by Walmart, citing potential health risk from Listeria monocytogenes, according to the U.S. Food and Drug Administration. In the initial recall, a limited quantity of watermelon chunks from select stores were included. Country Fresh further extended the recall to include various containers of "Freshness Guaranteed" fruits.

from RTT - Biotech https://ift.tt/34jafXe
via IFTTT

Aziyo Biologics To Debut On Nasdaq On Oct 8

Silver Spring, Maryland-based Aziyo Biologics is scheduled to go public on the Nasdaq Global Select Market under the symbol "AZYO" on October 8, 2020.

from RTT - Biotech https://ift.tt/3iAhAa6
via IFTTT

Aziyo Biologics To Debut On Nasdaq On Oct 8

Silver Spring, Maryland-based Aziyo Biologics is scheduled to go public on the Nasdaq Global Select Market under the symbol "AZYO" on October 8, 2020.

from RTT - Earnings https://ift.tt/3iAhAa6
via IFTTT

Rishi Sunak: UK needs to protect tech secrets from foreign investors

New state aid rules required to stop hostile countries getting access to firms, says chancellor

Britain needs new state aid rules in order to be able to protect itself against hostile states intent on stealing technological secrets and jobs, Rishi Sunak has said.

The chancellor said the UK had benefited from foreign investment but the government had to keep its eyes wide open to possible threats.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/3iiWX28

Trump's Positive Coronavirus Test May Weigh On Wall Street

The major U.S. index futures are currently pointing to a sharply lower open on Friday, with stocks likely to give back ground after moving notably higher over the two previous sessions.

from RTT - Market Analysis https://ift.tt/3ndnvp2
via IFTTT

New Asda owners Mohsin and Zuber Issa - the Blackburn billionaire brothers

The Issas once worked at their parents’ petrol station. Now they own 6,000 forecourts in 10 countries

• Issa brothers buy Asda in £6.8bn deal

Mohsin and Zuber Issa were cleaning the toilets at their parents’ petrol station, they say, when they hit upon the idea of transforming the filling station into a “shopping destination”.

It turned out to be quite a big idea … their petrol station empire has since expanded to nearly 6,000 forecourts across 10 countries. It has turned the brothers into billionaires and on Friday it provided them with the firepower to take control of the vast Asda supermarket chain.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/33mLtWW

Pre-market Movers In Healthcare Sector: XTNT, NNOX, VXRT, INO, MESO.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3jrLJKa
via IFTTT

Asda sold to billionaire Issa brothers in £6.8bn deal

The pair and TDR Capital acquire majority ownership stake in supermarket

Asda has been sold to two billionaire brothers from Blackburn and the private equity firm TDR Capital in a deal that values the supermarket chain at £6.8bn.

On Friday, Asda, which is owned by the US retail giant Walmart, confirmed the sale to Mohsin and Zuber Issa, who made their fortunes running the EG Group petrol station group, and TDR.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/3jmVCZm

Cardiff Oncology Rakes In Over 200% Gain In 3 Months

Shares of Cardiff Oncology Inc. (CRDF) touched a new high of $16 in intraday trading on Sep.30, and that represents a gain of over 220 percent in 3 months, after our premium stock alert. The stock closed yesterday's (Oct.1) trading at $13.62, down 4.02%.

from RTT - Biotech https://ift.tt/3n9QMRr
via IFTTT

EU Begins 1st Rolling Review Of COVID-19 Vaccine, SLDB To Restart DMD Trial, ENLV Soars, TARA Abuzz

Today's Daily Dose brings you news about the first rolling review of a COVID-19 vaccine in the EU, reverse merger of privately held Chinook Therapeutics with Aduro, Enlivex Therapeutics' positive top-line results of Allocetra in COVID-19 trial, FDA lifting the clinical hold on Solid Biosciences' IGNITE DMD trial, and Vaccibody's deal with Roche to develop neoantigen cancer vaccines.

from RTT - Biotech https://ift.tt/3l4gcya
via IFTTT

DMM Vission Recalls Certain Lots Of Cleaner Hand Sanitizer

DMM Vission is recalling five lots of Cleaner Hand Sanitizer due to potential presence of methanol (wood alcohol), the U.S. Food & Drug Administration said in a statement. The company is yet to receive any reports of adverse events involving the product.

from RTT - Biotech https://ift.tt/3ipa6GJ
via IFTTT

Pulse Biosciences Initiates Pivotal Study Of CellFX System In Sebaceous Hyperplasia

Pulse Biosciences Inc.'s (PLSE) CellFX System has received Investigational Device Exemption approval from the FDA and a pivotal study evaluating this device in the treatment of sebaceous hyperplasia lesions has been initiated.

from RTT - Biotech https://ift.tt/3jlFTd1
via IFTTT

Continued Stimulus Optimism May Generate Early Buying Interest

The major U.S. index futures are pointing to a higher open on Thursday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/3ikM4g7
via IFTTT

Conagra Brands Guides Q2 Adjusted EPS In Line With View; Boosts Dividend 29% - Quick Facts

While reporting financial results for the first quarter of fiscal 2021 on Thursday, Conagra Brands, Inc. (CAG) provided only its adjusted earnings and organic net sales growth guidance for the second quarter of fiscal 2021.

from RTT - Earnings https://ift.tt/3n8pFGI
via IFTTT

Solid Biosciences: FDA Lifts Clinical Hold On IGNITE DMD Clinical Trial

Solid Biosciences Inc. (SLDB), said Thursday that the U.S. Food and Drug Administration or FDA has lifted the clinical hold placed on the company's IGNITE DMD Phase I/II clinical trial.

from RTT - Biotech https://ift.tt/36p25j0
via IFTTT

PepsiCo Q3 Results Top Estimates; Reinstates Core EPS Outlook Above Estimates

Snack and beverage giant PepsiCo Inc. (PEP) on Thursday reported a 16 percent decline in net income for the third quarter, reflecting revenue growth on continued strength in its global snacks and food business and improvement in its global beverage business. Both core earnings per share and net revenues for the quarter beat analysts' estimates.

from RTT - Earnings https://ift.tt/3jqmSXa
via IFTTT

Pfizer's Gene Therapy Candidate For Duchenne Muscular Dystrophy Receives Fast Track designation

Pfizer Inc. (PFE) said the company's investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the FDA. The designation was granted based on data from the phase 1b study that indicated that the intravenous administration of PF-06939926 was well-tolerated during the infusion period and dystrophin expression levels were sustained over a 12-month period.

from RTT - Biotech https://ift.tt/3cMGP7L
via IFTTT

Pre-market Movers In Healthcare Sector: AMAG, PRPH, GENE, ZSAN, SELB.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3l0nO4I
via IFTTT

SELB Down But Not Out, PFE Takes 9.9% Stake In CStone, ZSAN Plunges, AMAG On The Block?

Today's Daily Dose brings you news about AMAG reportedly in talks with Covis Pharma about being acquired, Iterum's progress with Sulopenem, Pfizer's stake in CStone, Selecta's Gout trial results, and FDA notification to Zosano over migraine treatment Qtrypta.

from RTT - Biotech https://ift.tt/3jlMCnj
via IFTTT